Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 289.30M | $ 1.05B | $ 232.70M | $ 1.60B | $ 415.50M |
Total Assets | $ 28.53B | $ 25.76B | $ 23.41B | $ 21.59B | $ 20.35B |
Total Debt | $ 9.37B | $ 9.03B | $ 9.11B | $ 9.41B | $ 10.06B |
Net Debt | $ 9.08B | $ 7.98B | $ 8.88B | $ 7.80B | $ 9.64B |
Total Liabilities | $ 18.69B | $ 16.59B | $ 16.32B | $ 14.91B | $ 15.16B |
Stockholders Equity | $ 9.79B | $ 9.13B | $ 7.09B | $ 6.68B | $ 5.19B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |